docetaxel

The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia

Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug oxaliplatin

With this, the company has secured 511 marketing approvals for its oncology products across 66 countrles

With this, the number of marketing approvals for its oncology products across 76 countries has gone up to 506

With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503

This marketing authorisation from the largest GCC market will enable Venus Remedies to establish a strong foothold in GCC and MENA…

The approval is based on positive results of the phase-III Arasens trial that demonstrated darolutamide plus Androgen Deprivation…